FDA Inspection 1096105 — Mark Noar, MD

Mark Noar, MD — FEI 3014503085

The FDA completed an inspection of Mark Noar, MD on Jun 21, 2019 in Towson, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jun 21, 2019
Fiscal Year
2019
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Towson, MD (United States)

Additional details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.